Based on recent data, Ovid Therapeutics Inc. (OVID) shows an Average True Range (ATR) of 0.11 and an Enterprise Value of 241.7M. Its average trading volume over the past 3 months is 3.07M, indicating liquidity. These fundamental metrics provide insight into OVID's underlying financial health and market activity.
| ATR | 0.11 |
| Enterprise Value | 241.7M |
| Avg Vol (3 Months) | 3.07M |
| Avg Vol (10 Days) | 1.63M |
Ovid Therapeutics Inc. (OVID) technical indicators as of May 4, 2026: the SMA 20 is 8.06%, SMA 50 at 2.94%, and SMA 200 at 46.69%. The RSI 14 value is 56.14, suggesting its current momentum. These technical analysis signals help assess OVID's price trends and potential future movements.
| SMA 20 | 8.06% |
| SMA 50 | 2.94% |
| SMA 200 | 46.69% |
| RSI 14 | 56.14 |
Ovid Therapeutics Inc. (OVID) stock performance overview as of May 4, 2026: The 52-week high is $3.11 (currently -17.91% below), and the 52-week low is $0.27 (currently 580.41% above). Over the past year, OVID's performance is 108.22%, compared to the S&P 500's 16.14% change.
| 52-Week High | 3.11 |
| 52-Week High Chg | -17.91% |
| 52-Week Low | 0.2701 |
| 52-Week Low Chg | +580.41% |
| S&P 500 52-Week Chg | 16.14% |
According to market data, Ovid Therapeutics Inc. (OVID) stock's recent performance metrics show that over the last month, OVID is 2.7%, with a Year-to-Date (YTD) performance of -6.75%. Over the past year, the stock has seen a 108.22% change. These figures summarize OVID's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 2.79 | 3.11 | 3.11 | 3.11 | 3.11 | 3.11 |
| Low | 2.58 | 2.02 | 1.36 | 1.18 | 0.2701 | 1.36 |
| Performance | -5.59% | +2.70% | +2.70% | +151.07% | +108.22% | -6.75% |
According to current financial data, OVID stock's P/E (TTM) ratio is -13.09, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for OVID, including P/S (50.74), P/B (1.74), and P/FCF (-9.60), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | OVID | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -13.09 | -1.22 | -5.12 | 32.59 |
| P/S (TTM) | 50.74 | 3.69 | 464.32 | 5.98 |
| P/B (TTM) | 1.74 | 1.79 | 8628 | 4.69 |
| P/FCF (TTM) | -9.6 | -2.41 | -466.93 | 32.59 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep